参考范围内的甲状腺功能检查与骨折:前瞻性队列的个体参与者分析
该研究对13项前瞻性队列进行个体参与者数据分析,纳入基线TSH 0.45至4.49 mIU/L的成人,评估TSH与FT4和 incident 骨折的关联。在659,059人年中,56,835名参与者中2,565人发生髋部骨折(4.5%;12项研究有髋部骨折数据)。TSH 0.45至0.99 mIU/L组髋部骨折校正HR为1.25(95%CI 1.05至1.49),FT4每增加一个标准差髋部骨折HR为1.22(95%CI 1.11至1.35)。
要点
- 在甲状腺功能正常成人中,较低TSH和较高FT4与髋部骨折风险增加相关。
- TSH 0.45至0.99 mIU/L组髋部骨折校正HR为1.25(95%CI 1.05至1.49),趋势P=0.004。
- FT4每增加一个标准差,髋部骨折校正HR为1.22(95%CI 1.11至1.35)。
核心结论
- 在甲状腺功能正常成人中,较低TSH和较高FT4与髋部骨折风险增加相关。
- 这些发现可能有助于完善甲状腺功能检查最佳范围的定义。
研究设计与样本
- 个体参与者数据分析,纳入13项前瞻性队列研究,基线检查在1981年至2002年间。
- 参与者为基线TSH 0.45至4.49 mIU/L的成人。
- 主要结局为 incident 髋部骨折;次要结局为 any、非椎体和椎体骨折。
- 结果以校正年龄和性别的风险比(HR)及95%置信区间(CI)表示。
- TSH按五个类别研究:0.45至0.99 mIU/L;1.00至1.49 mIU/L;1.50至2.49 mIU/L;2.50至3.49 mIU/L;3.50至4.49 mIU/L(参照组)。
主要发现
- 在659,059人年中,56,835名参与者中2,565人发生髋部骨折(4.5%;12项研究有髋部骨折数据)。
- TSH 0.45至0.99 mIU/L组髋部骨折汇总校正HR(95%CI)为1.25(1.05至1.49)。
- TSH 1.00至1.49 mIU/L组髋部骨折汇总校正HR(95%CI)为1.19(1.01至1.41)。
- TSH 1.50至2.49 mIU/L组髋部骨折汇总校正HR(95%CI)为1.09(0.93至1.28);TSH 2.50至3.49 mIU/L组为1.12(0.94至1.33);趋势P=0.004。
- FT4每增加一个标准差,髋部骨折HR(95%CI)为1.22(1.11至1.35)。
关键数值与推荐
- TSH 0.45至0.99 mIU/L组髋部骨折校正HR为1.25(95%CI 1.05至1.49)。
- TSH 1.00至1.49 mIU/L组髋部骨折校正HR为1.19(95%CI 1.01至1.41)。
- TSH 1.50至2.49 mIU/L组髋部骨折校正HR为1.09(95%CI 0.93至1.28)。
- TSH 2.50至3.49 mIU/L组髋部骨折校正HR为1.12(95%CI 0.94至1.33);趋势P=0.004。
- FT4每增加一个标准差,髋部骨折HR为1.22(95%CI 1.11至1.35)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hyperthyroidism is associated with increased fracture risk, but it is not clear if lower thyroid-stimulating hormone (TSH) and higher free thyroxine (FT4) in euthyroid individuals are associated with fracture risk. OBJECTIVE: To evaluate the association of TSH and FT4 with incident fractures in euthyroid individuals. DESIGN: Individual participant data analysis. SETTING: Thirteen prospective cohort studies with baseline examinations between 1981 and 2002. PARTICIPANTS: Adults with baseline TSH 0.45 to 4.49 mIU/L. MAIN OUTCOME MEASURES: Primary outcome was incident hip fracture. Secondary outcomes were any, nonvertebral, and vertebral fractures. Results were presented as hazard ratios (HRs) with 95% confidence interval (CI) adjusted for age and sex. For clinical relevance, we studied TSH according to five categories: 0.45 to 0.99 mIU/L; 1.00 to 1.49 mIU/L; 1.50 to 2.49 mIU/L; 2.50 to 3.49 mIU/L; and 3.50 to 4.49 mIU/L (reference). FT4 was assessed as study-specific standard deviation increase, because assays varied between cohorts. RESULTS: During 659,059 person-years, 2,565 out of 56,835 participants had hip fracture (4.5%; 12 studies with data on hip fracture). The pooled adjusted HR (95% CI) for hip fracture was 1.25 (1.05 to 1.49) for TSH 0.45 to 0.99 mIU/L, 1.19 (1.01 to 1.41) for TSH 1.00 to 1.49 mIU/L, 1.09 (0.93 to 1.28) for TSH 1.50 to 2.49 mIU/L, and 1.12 (0.94 to 1.33) for TSH 2.50 to 3.49 mIU/L (P for trend = 0.004). Hip fracture was also associated with FT4 [HR (95% CI) 1.22 (1.11 to 1.35) per one standard deviation increase in FT4]. FT4 only was associated with any and nonvertebral fractures. Results remained similar in sensitivity analyses. CONCLUSIONS: Among euthyroid adults, lower TSH and higher FT4 are associated with an increased risk of hip fracture. These findings may help refine the definition of optimal ranges of thyroid function tests.
引用
- Aubert CE, Floriani C, Bauer DC, et al. Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts. J Clin Endocrinol Metab. 2017. PMID: 28482002. doi:10.1210/jc.2017-00294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。